Emmanuel Ligner, CEO of self-described bioprocess “critical actor” Cytiva talks us through the changing biomanufacturing landscape and unveils his firm’s sustainability report in the latest BioProcess Insider Expression Platform podcast.
In 2021, Cytiva launched a survey measuring industry’s confidence in the biopharma space. Focusing across five pillars – supply chain resilience, talent pool, the R&D ecosystem, manufacturing agility, and government policy and regulation – the Biopharma Resilience Index averaged an overall score of 6.6 out of 10 in 2021.
Feedback from 2022’s survey showed “COVID was a wake-up call,” Emmanuel Ligner told us at BIO in San Diego last month. “Suddenly people realized we need to do something different; we need to pay more attention to the supply chain. We also saw governments reacting very well in many countries, and that was a very positive thing. Overall, 63% said [COVID] was a wakeup call and I think that was good for the industry.”
Ligner also spoke about his firm’s sustainability efforts, citing a recently published report on the issue.
Listen below, or download at Spotify, Amazon, iTunes, or wherever you get your podcasts.
You May Also Like
schedl_b_and_w.jpg?width=100&auto=webp&quality=80&disable=upscale "Picture of Dan Stanton")
schedl_b_and_w.jpg?width=400&auto=webp&quality=80&disable=upscale "Dan Stanton")
